映恩生物

The IPO application of biotech company映恩生物 (likely Duality Biologics) has been accepted for review. The Shanghai Stock Exchange has formally accepted the company's application to proceed with the listing process. This marks a significant step towards going public.

AI-generated: summaries written by AI from the linked sources. How we use AI